Hologic Executive and Leadership Team

Karleen Oberton, the Chief Financial Officer at Hologic, directs all global financial operations and capital allocation strategies. Overseeing fiscal planning, the Chief Financial Officer ensures the company maintains a robust balance sheet to support research and development in medical imaging and diagnostic systems. This leadership role involves managing investor relations and optimizing cost structures to fuel long-term growth across North American and international markets. By aligning financial resources with the core mission of improving women's health, Karleen Oberton directly impacts the ability of the organization to scale production of advanced surgical tools. Through rigorous oversight of financial reporting and risk management, Oberton secures the capital necessary for continuous innovation in infectious disease testing and gynecological care, ultimately driving sustainable value for shareholders and clinical partners worldwide.

Essex Mitchell, the Chief Operating Officer at Hologic, manages the end-to-end supply chain and manufacturing excellence for the company's diagnostic and imaging portfolio. Overseeing global production facilities, the Chief Operating Officer ensures high-quality delivery of medical devices that support early detection and treatment. This leadership role involves streamlining operational workflows to meet the increasing demand for breast health and surgical solutions across diverse healthcare environments. By optimizing manufacturing efficiency and logistics, Essex Mitchell directly impacts the availability of critical diagnostic products for clinical professionals. Through the implementation of advanced process improvements, Mitchell maintains the operational agility required to navigate complex global markets, ensuring that the organization consistently meets the highest standards of care for patients requiring specialized medical interventions.

Jennifer Schneiders, the President, Diagnostic Solutions at Hologic, leads the development and commercialization of advanced diagnostic products and infectious disease testing systems. Overseeing the diagnostic business unit, the President, Diagnostic Solutions ensures the delivery of high-impact clinical tools that facilitate early detection and improved patient outcomes. This leadership role involves collaborating with research teams to expand the portfolio of molecular diagnostics and screening technologies. By driving market adoption of innovative testing platforms, Jennifer Schneiders directly impacts the standard of care in gynecological and infectious disease settings. Through strategic product lifecycle management, Schneiders ensures that the diagnostic division remains at the forefront of medical technology, providing healthcare providers with the precision and speed required to address complex health challenges across global patient populations.

Jan Verstreken, the Group President, International at Hologic, directs the commercial strategy and market expansion efforts across all regions outside the United States. Overseeing international operations, the Group President, International ensures the successful deployment of breast health, surgical, and diagnostic systems in diverse healthcare markets. This leadership role involves building strong partnerships with regional health authorities and clinical institutions to raise standards of care globally. By tailoring commercial approaches to specific regional needs, Jan Verstreken directly impacts the company's ability to deliver life-saving medical technology to a broader patient base. Through the management of cross-functional teams, Verstreken drives revenue growth and operational success in EMEA, Asia-Pacific, and Latin American markets, ensuring that the organization's mission of improving women's health remains a central focus of international clinical practice.

Paul Malenchini, the Chief Information Officer at Hologic, architects the digital infrastructure and cybersecurity frameworks supporting the company's global medical technology operations. Overseeing enterprise data systems, the Chief Information Officer ensures seamless integration between diagnostic imaging platforms and clinical software solutions. This leadership role involves driving digital transformation initiatives that enhance data security and operational connectivity across the entire organization. By leveraging advanced analytics and cloud-based systems, Paul Malenchini directly impacts the efficiency of infectious disease testing and gynecological care workflows. Through the modernization of internal technology stacks, Malenchini supports the broader mission of providing healthcare professionals with reliable, data-driven tools. This strategic focus on digital resilience enables the company to maintain a competitive edge in the rapidly evolving landscape of medical diagnostics and patient care.